-
Founded in:
2013-04-22 -
Country:
China -
Address:
No. 16, Yaogu Erheng Road, Yaogu Industrial Park, Haikou National High-tech Industrial Development Zone, Hainan Province -
Tax NO.:
91460000062331438Q -
Registered Funds:
200 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 10α-Methoxy-1,6-dimethylergoline-8β-methylol-5-bromonicotinate |
This product is a semi-synthetic ergot alkaloid derivative. It has α-receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to increase nerve conduction, enhance the synthesis of brain protein, and improve brain function.
More
This product is a semi-synthetic ergot alkaloid derivative. It has α-receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to increase nerve conduction, enhance the synthesis of brain protein, and improve brain function. |
0 | ||
| 10α-Methoxy-1,6-dimethylergoline-8β-methylol-5-bromonicotinate |
This product is a semi-synthetic ergot alkaloid derivative. It has α-receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to increase nerve conduction, enhance the synthesis of brain protein, and improve brain function.
More
This product is a semi-synthetic ergot alkaloid derivative. It has α-receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to increase nerve conduction, enhance the synthesis of brain protein, and improve brain function. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 10α-Methoxy-1,6-dimethylergoline-8β-methylol-5-bromonicotinate |
This product is a semi-synthetic ergot alkaloid derivative. It has α-receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to increase nerve conduction, enhance the synthesis of brain protein, and improve brain function.
More
This product is a semi-synthetic ergot alkaloid derivative. It has α-receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to increase nerve conduction, enhance the synthesis of brain protein, and improve brain function. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nicergoline |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
27848-84-6 | 35 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tiopronin |
Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio.
More
Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio. |
1953-02-2 | 55 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tiopronin |
Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio.
More
Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio. |
1953-02-2 | 55 |